Skip to Content

Your Location Within Site:


1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines

Title1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
Publication TypeJournal Article
Year of Publication2011
AuthorsFröhlich, R. F. G., Furneaux R. H., Mahuran D. J., Saf R., Stütz A. E., Tropak M. B., Wicki J., Withers S. G., and Wrodnigg T. M.
IRL TeamCarbohydrate Chemistry
JournalCarbohydrate Research
Volume346
Pagination1592-1598
Keywords4 o isopropylidene 1, 5 dideoxy 1, 5 imino dextro galactitol, 6 diaminohexane, alkylation, animal cell, article, beta galactosidase, beta glucosidase, Carboxylic acids, Cell culture, chaperone, drug structure, enzyme activity, enzyme inhibition, fibroblast, Fluorescence, fluorescent dye, Galactosidases, glycosidase inhibitor, GM1 gangliosidosis, GM1-gangliosidosis, human, human cell, Iminoalditol, Molecular chaperone, n (dansylamino)hexylaminocarbonylpentyl 1, n (dansylaminohexylamino)hexyl 3, n aminohexyl 1 deoxy dextro galactonojirimycin, n bis(dansylaminohexyl)aminocarbonylpentyl 1, n bis(dansylaminohexyl)aminohexyl 1, n bis(dansylaminohexyl)aminohexyl 3, n carboxypentyl 1 deoxy dextro galactonojirimycin, n dansyl 1, n [(dansylaminohexyl) n octanoylamino]hexyl 1, n [(dansylaminohexyl) n octanoylamino]hexyl 3, N-alkylation, nonhuman, priority journal, substitution reaction, Synthesis (chemical), unclassified drug
Abstract Two simple and reliably accessible intermediates, N-carboxypentyl- and N-aminohexyl-1-deoxy-d-galactonojirimycin were employed for the synthesis of a set of terminally N-dansyl substituted derivatives. Reaction of the terminal carboxylic acid of N-carboxypentyl-1-deoxy-d-galactonojirimycin with N-dansyl-1,6-diaminohexane provided the chain-extended fluorescent derivative. Employing bis(6-dansylaminohexyl)amine, the corresponding branched di-N-dansyl compound was obtained. Partially protected N-aminohexyl-1-deoxy-d- galactonojirimycin served as intermediate for two additional chain-extended fluorescent 1-deoxy-d-galactonojirimycin (1-DGJ) derivatives featuring terminal dansyl groups in the N-alkyl substituent. These new compounds are strong inhibitors of d-galactosidases and may serve as leads en route to pharmacological chaperones for GM1-gangliosidosis. © 2011 Elsevier Ltd. All rights reserved.
URLhttp://www.scopus.com/inward/record.url?eid=2-s2.0-79959980422&partnerID=40&md5=80fe5b6d9173e51e83b0e3aa66ad09e9
DOI10.1016/j.carres.2011.05.010